Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 461.00
-2.55 (-0.55%)
At close: Jul 27, 2026
Bliss GVS Pharma Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 9,271 | 9,271 | 8,097 | 7,702 | 7,516 | 7,475 |
Revenue Growth | 14.50% | 14.50% | 5.13% | 2.48% | 0.55% | 29.49% |
Gross Profit Gross Profit Growth | 4,793 | 4,793 | 3,792 | 3,695 | 3,380 | 3,444 |
Operating Income Operating Income Growth | 1,311 | 1,311 | 977.58 | 1,242 | 986.49 | 1,013 |
Net Income Net Income Growth | 1,291 | 1,291 | 842.99 | 754.54 | 708.59 | 150.4 |
Earnings Per Share EPS Growth | 12.00 | 12.00 | 7.95 | 7.11 | 6.72 | 1.43 |
EPS Growth | 50.94% | 50.94% | 11.81% | 5.80% | 369.93% | -77.97% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 673.41 | 673.41 | 530.18 | 444.42 | 391.62 | 562.32 |
Outside India Outside India Growth | 8,498 | 8,498 | 7,488 | 7,215 | 7,083 | 6,817 |
Total Total Growth | 9,172 | 9,172 | 8,018 | 7,659 | 7,474 | 7,379 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,886 | 1,886 | 1,413 | 1,404 | 683.59 | 1,349 |
Total Debt Total Debt Growth | 217.5 | 217.5 | 881.04 | 998.4 | 1,019 | 1,094 |
Net Cash (Debt) Net Cash Growth | 1,669 | 1,669 | 532.41 | 405.27 | -335.39 | 255.5 |
Net Cash Growth | 213.45% | 213.45% | 31.37% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 15.51 | 15.51 | 5.02 | 3.82 | -3.18 | 2.43 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,387 | 1,387 | 1,059 | 1,028 | 343.14 | 1,355 |
Capital Expenditures CapEx Growth | -568.31 | -568.31 | -762.86 | -283.29 | -937.99 | -740.03 |
Free Cash Flow Free Cash Flow Growth | 818.87 | 818.87 | 296.27 | 744.87 | -594.86 | 614.78 |
Free Cash Flow Growth | 176.39% | 176.39% | -60.23% | - | - | 12.09% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 51.70% | 51.70% | 46.83% | 47.98% | 44.98% | 46.07% |
Operating Margin | 14.14% | 14.14% | 12.07% | 16.13% | 13.13% | 13.55% |
Pretax Margin | 20.45% | 20.45% | 15.52% | 15.17% | 14.11% | 7.25% |
Profit Margin | 13.93% | 13.93% | 10.41% | 9.80% | 9.43% | 2.01% |
FCF Margin | 8.83% | 8.83% | 3.66% | 9.67% | -7.92% | 8.22% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 1.500 | 0.500 | 0.500 | 0.500 | 0.500 |
Dividend Per Share Growth | 200.00% | 200.00% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.43% | 0.70% | 0.43% | 0.45% | 0.71% | 0.67% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 38.42 | 17.66 | 14.69 | 15.63 | 10.47 | 53.05 |
Forward PE | - | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 |
P/FCF Ratio | 59.71 | 27.85 | 41.81 | 15.83 | - | 12.98 |
PS Ratio | 5.27 | 2.46 | 1.53 | 1.53 | 0.99 | 1.07 |